These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29338702)

  • 1. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
    Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.
    Hofstraat SHI; Falla AM; Duffell EF; Hahné SJM; Amato-Gauci AJ; Veldhuijzen IK; Tavoschi L
    Epidemiol Infect; 2017 Oct; 145(14):2873-2885. PubMed ID: 28891457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
    Seedat F; Hargreaves S; Nellums LB; Ouyang J; Brown M; Friedland JS
    Lancet Infect Dis; 2018 Sep; 18(9):e259-e271. PubMed ID: 29778396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA.
    Deblonde J; Sasse A; Del Amo J; Burns F; Delpech V; Cowan S; Levoy M; Keith L; Pharris A; Amato-Gauci A; Noori T
    BMC Public Health; 2015 Dec; 15():1228. PubMed ID: 26654427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; Noori T; van der Werf MJ; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic analysis and estimation of hepatitis C cases in migrant populations living in Spain: is a country-based screening strategy appropriate?
    Alarcón Linares ME; Torres Cantero A; Subirá C; Ramírez Rubio O; Crespo J; Lazarus JV; Requena-Méndez A
    Rev Esp Enferm Dig; 2019 Aug; 111(8):615-625. PubMed ID: 31317761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review.
    Greenaway C; Makarenko I; Chakra CNA; Alabdulkarim B; Christensen R; Palayew A; Tran A; Staub L; Pareek M; Meerpohl JJ; Noori T; Veldhuijzen I; Pottie K; Castelli F; Morton RL
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30223539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries.
    Ahmad AA; Falla AM; Duffell E; Noori T; Bechini A; Reintjes R; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):34. PubMed ID: 29325525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.
    Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27039665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.
    Hollo V; Kotila SM; Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27035746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy.
    Fakoya I; Álvarez-del Arco D; Woode-Owusu M; Monge S; Rivero-Montesdeoca Y; Delpech V; Rice B; Noori T; Pharris A; Amato-Gauci AJ; del Amo J; Burns FM
    BMC Public Health; 2015 Jun; 15():561. PubMed ID: 26085030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
    Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
    BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU/EEA region.
    Moonen CPB; den Heijer CDJ; Dukers-Muijrers NHTM; van Dreumel R; Steins SCJ; Hoebe CJPA
    Front Public Health; 2023; 11():1118227. PubMed ID: 36875381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
    Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
    Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles among migrants in the European Union and the European Economic Area.
    Williams GA; Bacci S; Shadwick R; Tillmann T; Rechel B; Noori T; Suk JE; Odone A; Ingleby JD; Mladovsky P; Mckee M
    Scand J Public Health; 2016 Feb; 44(1):6-13. PubMed ID: 26563254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review.
    Bivegete S; McNaughton AL; Trickey A; Thornton Z; Scanlan B; Lim AG; Nerlander L; Fraser H; Walker JG; Hickman M; Vickerman P; Johnson H; Duffell E; Brooks-Pollock E; Christensen H
    Euro Surveill; 2023 Jul; 28(30):. PubMed ID: 37498533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis among migrant populations in the European Union and the European Economic Area.
    Odone A; Tillmann T; Sandgren A; Williams G; Rechel B; Ingleby D; Noori T; Mladovsky P; McKee M
    Eur J Public Health; 2015 Jun; 25(3):506-12. PubMed ID: 25500265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
    European Union HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.
    Thomadakis C; Gountas I; Duffell E; Gountas K; Bluemel B; Seyler T; Pericoli FM; Kászoni-Rückerl I; El-Khatib Z; Busch M; Schmutterer I; Vanwolleghem T; Klamer S; Plettinckx E; Mortgat L; Van Beckhoven D; Varleva T; Kosanovic Licina ML; Nemeth Blazic T; Nonković D; Theophanous F; Nemecek V; Maly M; Christensen PB; Cowan S; Rüütel K; Brummer-Korvenkontio H; Brouard C; Steffen G; Krings A; Dudareva S; Zimmermann R; Nikolopoulou G; Molnár Z; Kozma E; Gottfredsson M; Murphy N; Kondili LA; Tosti ME; Ciccaglione AR; Suligoi B; Nikiforova R; Putnina R; Jancoriene L; Seguin-Devaux C; Melillo T; Boyd A; van der Valk M; Op de Coul E; Whittaker R; Kløvstad H; Stępień M; Rosińska M; Valente C; Marinho RT; Popovici O; Avdičová M; Kerlik J; Klavs I; Maticic M; Diaz A; Del Amo J; Lundberg Ederth J; Axelsson M; Nikolopoulos G
    Lancet Reg Health Eur; 2024 Jan; 36():100792. PubMed ID: 38188273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.